Testing a telehealth program to help patients with advanced cancer manage symptoms
Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer
['FUNDING_R01'] · DUKE UNIVERSITY · NIH-10936635
This study is testing a friendly online program called ENGAGE that helps people with advanced cancer manage tough symptoms like pain and fatigue, using helpful techniques to improve their daily lives and well-being.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-10936635 on ClinicalTrials.gov |
What this research studies
This research investigates a telehealth-delivered psychosocial intervention called ENGAGE, aimed at helping patients with advanced cancer manage symptoms like pain, fatigue, and distress. The program incorporates Acceptance and Commitment Therapy (ACT) and traditional Cognitive Behavioral Therapy (CBT) techniques to improve patients' quality of life by teaching them skills to cope with their symptoms and engage in meaningful activities. Participants will receive support through virtual sessions, making it accessible and convenient for those facing advanced cancer. The goal is to reduce symptom interference in daily life and enhance overall well-being.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with advanced cancer who experience significant pain, fatigue, or distress.
Not a fit: Patients with early-stage cancer or those not experiencing significant symptom interference may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for patients with advanced cancer by providing effective coping strategies for managing distressing symptoms.
How similar studies have performed: Previous pilot trials of similar ACT-based interventions have shown promising results, indicating potential for success in this larger efficacy trial.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WINGER, JOSEPH GILES — DUKE UNIVERSITY
- Study coordinator: WINGER, JOSEPH GILES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Advanced Cancer, Cancers